HTA of Advate in the treatment and the prophylaxis of Hemophilia A: ethical considerations

The safety, tolerability and efficacy both in terms of prophylaxis and of the therapy of bleeding episodes achievable with Advate® enables us to issue an overall favorable ethical judgment. It is nonetheless advisable that decision makers work towards the creation of procedures of continuity in treatment and towards global care for patients, as well as towards guaranteeing equal access to medicine for all patients.